4-oxystilbene compounds are selective ligands for neuronal nicotinic αBungarotoxin receptors

British Journal of Pharmacology

Volumn 124, Issue 6, 1998, Pages 1197-1206

  Gotti, C ^a,b   Balestra, B ^a,b   Moretti, M ^a,b   Rovati, G E ^b   Maggi, L ^c   Rossoni, G ^b   Berti, F ^b   Villa, L ^b   Pallavicini, M ^b   Clementi, F ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Bungarotoxin; Bungarotoxin receptors; 4 Oxystilbene; Chick optic lobe; Epibatidine; Neuronal nicotinic receptors; Subtypes

Indexed keywords

4 OXYSTILBENE; ANTIBODY; BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; IODINE 125; LIGAND; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; STILBENE DERIVATIVE; STILONIUM IODIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHEMICAL STRUCTURE; CHICKEN; CONCENTRATION RESPONSE; CONTROLLED STUDY; GUINEA PIG; HEMIDIAPHRAGM; MEMBRANE; NONHUMAN; OOCYTE; OPTIC LOBE; PRIORITY JOURNAL; RECEPTOR BINDING; STEREOISOMERISM; STOMACH; VAGUS NERVE STIMULATION;

ANIMALS; ANTIBODY SPECIFICITY; BUNGAROTOXINS; CELL LINE; CHICKENS; GUINEA PIGS; IODINE RADIOISOTOPES; NEURONS; RADIOLIGAND ASSAY; RATS; RECEPTORS, NICOTINIC; RECOMBINANT PROTEINS; STILBENES; SYNAPTIC TRANSMISSION; VAGUS NERVE;

EID: 15644383094     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701957     Document Type: Article

References (29)

1. ABREO, M., LIN N-H., GARVEY D., GUNN, D., HETTINGER A.M., VASICAK, J., PAVLICK, P., MARTIN, Y., DONELLY-ROBERTS, D., ANDERSON, D, SULLIVAN, J., WILLIAMS, M., ARNERIC, S. & HOLLADAY, M. (1996). Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. J. Med. Chem., 39, 817-825.
2. BULBRING E. (1946). Observation on the isolated phrenic nerve hemidiaphragm preparation of the rat. Br. J. Pharmac. Chemother., 1, 38-61.
3. CAVALLINI, G., MANTEGAZZA, P., MASSARINI, E. & TOMMASINI, R. (1953). Sull'attività ganglioplegica di alcuni derivati alchilaminici dello stilbene e del difenile. Il Farmaco, 6, 317-331.
4. CODIGNOLA, A., TARRONI, P., CATTANEO, M.G., VICENTINI, L.M., CLEMENTI, F. & SHER, E. (1994). Serotonin release and cell proliferation are under the control of α-bungarotoxin-sensitive nicotinic receptors in small-cell lung carcinoma cell lines. FEBS Lett., 342, 286-290.
5. CONROY, W.G. & BERG, D.K. (1995). Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J. Biol. Chem., 270, 4424-4431.
6. DANI, J.A. & HEINEMANN, S. (1996). Molecular and cellular aspects of nicotine abuse. Neuron, 16, 905-908.
7. DRAPER, N.R. & SMITH, H. (1966). Applied regression analysis. New York: Wiley.
8. ELLIOTT, R., KOPECKA, H., GUNN, D., LIN, N., GARVEY, D., RYTHER, K., HOLLADAY, M., ANDERSON, D., CAMPBELL, J., SULLIVAN, J., BUCKLEY, M., GUNTHER, K., O'NEILL A., DECKER, M. & ARNERIC, S. (1996). 2-(Aryloxymethyl) azacyclic analogues as novel nicotinic acetylcholine receptor (neuronal nicotinic AChR) ligands. Bioorganic & Medical Chemistry letters, 19, 2283-2288.
9. FORSAYETH, J.R. & KOBRIN, E. (1997). Formation of oligomers containing the β3 and β4 subunits of the rat nicotinic receptor. J. Neurosci., 17, 1531-1538.
10. GERZANICH, V., PENG X., WANG, F., WELLS, G., ANAND, R., FLETCHER, S. & LINDSTROM J. (1995). Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol., 48, 774-782.
11. GOTTI, C., HANKE, W., MORETTI, M., BALLIVET, M., CLEMENTI, F. & BERTRAND, D. (1994). Pharmacology and biophysical properties of α7 and α7-α8 α-Bungarotoxin receptor subtypes immunopurified from the chick optic lobe. Eur. J. Neurosci., 6, 1281-1291.
12. GOTTI, C., FORNASARI, D. & CLEMENTI F. (1997a). Human neuronal nicotinic receptors. Progr. Neurobiol., 53, 199-237.
13. GOTTI, C., MORETTI, M., MAGGI, R., LONGHI, R., HANKE, W., KLINKE, N. & CLEMENTI, F. (1997b). α7 and α8 nicotinic receptor subtypes immunopurified from chick retina have different immunological, pharmacological and functional properties. Eur. J. Neurosci., 5, 1201-1211.
14. KEM, W., MAHNIR, V., PAPKE, R., & LINGLE, C. (1997). Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors. J. Pharmacol. & Exp. Therap., 283, 979-992.
15. MANTEGAZZA, P. & TOMMASINI, R. (1955). Central antinicotinic activity of 4-oxystilbene and 4-oxydiphenylethane derivatives. Arch. Int. Pharmacodyn., 4, 371-403.
16. MARKS, M.J., STITZEL, J.A. & COLLINS, A.C. (1989). Genetic influences on nicotine responses. Pharmacol. Biochem. Behav., 33, 667-678.
17. McGEHEE, D.S. & ROLE, L.W. (1995). Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol., 57, 521-546.
18. MILEDI, R., PARKER I. & SUMIKAWA, K. (1989). Fidia research foundation Neuroscience Award Lectures, 1987-1988 Raven: New York, 3, 57-90.
19. MUNSON, P.J. & RODBARD, D. (1980). LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220-239.
20. PALMA, E., BERTRAND, S., BINZONI, T. & BERTRAND D. (1996). Neuronal nicotinic α7 receptor expressed in Xenopus oocytes presents live putative binding sites for methyllycaconitine. J. Physiol (London). 491.1, 151-161.
21. PAPKE, R.L. (1993). The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity. Progr. Neurobiol., 41, 509-531.
22. PATON, W. & VANE J. (1963). An analysis of the responses of the isolated stomach to electrical stimulation and to drug. J. Physiol., 165, 10-46.
23. QUIK, M., CHAN, J. & PATRICK, J. (1994). α-Bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line. Brain Res., 655, 161-167.
24. ROLE, L.W. & BERG, K.D. (1996). Nicotinic receptors in the development and modulation of CNS synapses. Neuron, 16, 1077-1085.
25. ROVATI, G.E., RABIN, D. & MUNSON, P.J. (1991). Analysis, design and optimization of ligand binding experiments. In Horizon in Endocrinology (VoI II). ed. Maggi, M. & Geenen, E.V. pp. 155-167. New York: Serono Symposia Publication from Raven Press.
26. RUBBOLI, F., COURT, J.A., SALA, C., MORRIS, C., CHINI, B., PERRY, E. & CLEMENTI, F. (1994). Distribution of nicotinic receptors in the human hippocampus and thalamus. Eur. J. Neurosci., 6, 1596-1604.
27. SARGENT, P.B. (1993). The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci., 16, 403-443.
28. WHITING, P.J., LIU, R., MORLEY, B.J. & LINDSTROM, J.M. (1987). Structurally different neuronal nicotinic acetylcholine receptor subtypes purified and characterized using monoclonal antibodies. J. Neurosci., 7, 4005-4016.
29. WONNACOTT, S. (1997). Presynaptic nicotinic ACh receptors. Trends Neurosci., 20, 92-98.